Notes
J . Org. Chem., Vol. 65, No. 4, 2000 1229
determined the enantiomeric excess to be greater than 99%
(other enantiomer not observed). [R]D +14.7° (c 4.0, CH2Cl2).
(R)-3-Cycloh exyl-3-h yd r oxyp en ta n oic Acid , Ben zyl Es-
ter (3a ).10 From the resolution of 1a described above, column
chromatography (90% hexane, 10% ethyl acetate) of the crude
reaction mixture afforded 204 mg of the title compound (48%).
Separation of the enantiomers by chiral HPLC (Daicel Chiracel
OD-H column, flow rate 1.0 mL/min, 10% PrOH, 90% hexane
Tr 25.5 (S) and 26.7 (R) min) determined the enantiomer ratio
to be 24:1 (92% ee). [R]D +20.4° (c 6.0, CH2Cl2).
°C for 10.00 min, ramp @ 10.00 °C/min to 130 °C for 8.00 min,
ramp @ 10.00 °C/min to 160 °C for 5.00 min, Tr 12.4 (R) and
13.2 (S) min) determined the enantiomer ratio to be 20:1 (90%
ee). [R]D +37.2° (c 5.8, CH2Cl2). IR (NaCl): 1828 cm-1; 1H NMR
(300 MHz, CDCl3): δ 4.54-4.59 (m, 1H), 3.54 (dd, J ) 16.3, 5.9
Hz, 1H), 3.04 (dd, J ) 16.3, 4.3 Hz, 1H), 1.75-1.86 (m, 2H),
1.56-1.73 (m, 1H), 0.96 (d, J ) 6.50, 6H); 13C NMR (75 MHz,
CDCl3): δ 168.6, 70.4, 43.7, 43.6, 25.5, 22.9, 22.3; MS (EI, 70
eV): m/z 128 (M+), 113, 109, 104, 95, 91, 85, 71, 56. HRMS (FAB)
m/z cacld for C7H12O2: 128.0837. Found: 128.0835.
i
(S)-4-(1-Meth yleth yl)oxeta n -2-on e (2b).8a The general pro-
cedure with the following modifications was followed employing
1.0 g of 4-(1-methylethyl)oxetan-2-one (1b) and 759 mg of benzyl
alcohol (72 h reaction time). After the resolution was complete,
the reaction mixture was eluted through a silica gel pad with
ethyl ether. The filtrate was concentrated in vacuo and the
products separated by column chromatography (90% pentane,
10% ether) to afford 54 mg of the title compound (5.4%).
Separation of the enantiomers by chiral GC (Chiraldex G-TA
column, flow rate 0.5 mL/min, method: 100 °C for 10.00 min,
ramp @ 10.00 °C/min to 130 °C for 8.00 min, ramp @ 10.00 °C/
min to 160 °C for 5.00 min, Tr 9.9 (S) and 10.6 (R) min)
determined the enantiomeric excess to be 99%. [R]D +20.1° (c
(S)-3-Hyd r oxy-5-m eth ylh exa n oic Acid , Ben zyl Ester (3f).
From the resolution of 1f described above, column chromatog-
raphy (90% hexane, 10% ethyl acetate) of the crude reaction
mixture afforded 478 mg of the title compound (52%). Separation
of the enantiomers by chiral HPLC (Daicel Chiracel OD-H
i
column, flow rate 1.0 mL/min, 10% PrOH, 90% hexane Tr 5.9
(R) and 7.6 (S) min) determined the enantiomer ratio to be 16:1
1
(88% ee). [R]D +10.3° (c 6.5, CH2Cl2); IR (NaCl) 1730 cm-1; H
NMR (300 MHz, CDCl3) δ 7.38 (m, 5H), 5.17 (s, 2H), 4.12 (m,
1H), 2.75 (br s, 1H), 2.56 (dd, J ) 16.5 and 3.3 Hz, 1H), 2.45
(dd, J ) 16.5 and 8.7 Hz, 1H), 1.80 (m, 1H), 1.49 (ddd, J ) 14.0,
8.9, and 5.5 Hz, 1H), 1.18 (ddd, J ) 13.4, 8.7, and 4.4 Hz, 1H),
0.92 (d, J ) 6.6 Hz, 6H); 13C δ 172.5, 135.4, 128.4, 128.0 (2C),
66.2, 65.9, 45.4, 41.8, 24.4, 23.1, 21.7; TLC Rf 0.31 (20% ethyl
acetate, 80% hexane); MS (EI, 70 eV): m/z: 236 (M+). HRMS
(FAB) m/z cacld for C14H20O3: 236.1413. Found: 236.1418.
(R)-4-(9-Decylen yl)oxeta n -2-on e (2g). The general proce-
dure was followed employing 200 mg of 4-(9-decylenyl)oxetan-
2-one (1g) and 82 mg of benzyl alcohol (72 h reaction time).
Column chromatography (90% hexane, 10% ethyl acetate) of the
crude reaction mixture afforded 64 mg of the title compound
(32%). Separation of the enantiomers by chiral GC (Chiraldex
G-TA column, flow rate 0.5 mL/min, method: 100 °C for 10.00
min, ramp @ 5.00 °C/min to 130 °C for 12.00 min, ramp @ 10.00
°C/min to 160 °C for 15.00 min, Tr 38.5 (R) and 39.7 (S) min)
determined the enantiomeric excess to be greater than 99%
(other enantiomer not observed). [R]D +21.8° (c 4.7, CH2Cl2). IR
3.9, CH2Cl2). IR (NaCl): 1822 cm-1 1H NMR (300 MHz,
;
CDCl3): δ 4.20 (ddd, J ) 8.0, 5.7, 4.4 Hz, 1H), 3.44 (dd, J )
16.3, 5.6 Hz, 1H), 3.09 (dd, J ) 16.3, 4.4 Hz, 1H), 1.94 (m, 1H),
1.06 (d, J ) 6.6 Hz, 3H), 0.96 (d, J ) 6.8, 3H); 13C NMR (75
MHz, CDCl3): δ 168.7, 75.4, 40.4, 32.0, 17.1, 16.2; MS (CI,
isobutane): m/z 115 [M + H]+, 97, 71.
(R)-4-(2-P h en yleth yl)oxeta n -2-on e (2c).2a The general pro-
cedure was followed employing 500 mg of 4-(2-phenylethyl)-
oxetan-2-one (1c) and 246 mg of benzyl alcohol (30 h reaction
time). Column chromatography (90% hexane, 10% ethyl acetate)
of the crude reaction mixture afforded 189 mg of the title
compound (38%). Separation of the enantiomers by chiral HPLC
(Daicel Chiracel OD-H column, flow rate 1.0 mL/min, 10%
iPrOH, 90% hexane Tr16.2 (S) and 17.9 (R) min) determined the
enantiomeric excess to be 93%. [R]D +37.8° (c 2.4, CH2Cl2).
(R)-4-Bu tyloxeta n -2-on e (2d ).3g The general procedure was
followed employing 1.0 g of 4-isopropyloxetan-2-one (1d ) and 676
mg of benzyl alcohol (72 h reaction time). Column chromatog-
raphy (90% hexane, 10% ethyl acetate) of the crude reaction
mixture afforded 422 mg of the title compound (42%). Separation
of the enantiomers by chiral GC (Chiraldex G-TA column, flow
rate 0.5 mL/min, method: 100 °C for 10.00 min, ramp @ 10.00
°C/min to 130 °C for 8.00 min, ramp @ 10.00 °C/min to 160 °C
for 5.00 min, Tr 11.3 (R) and 11.9 (S) min) determined the
enantiomeric excess to be 97%. [R]D +21.5° (c 5.9, CH2Cl2). IR
1
(NaCl): 3075, 1828, 1125 cm-1; H NMR (300 MHz, CDCl3): δ
5.76-5.85 (m, 1H), 4.90-5.02 (m, 2H), 4.46-4.52 (m, 1H), 3.50
(dd, J ) 16.2, 5.6 Hz, 1H), 3.05 (dd, J ) 16.2, 4.3 Hz, 1H), 2.00-
2.05 (m, 2H), 1.73-1.86 (m, 2H), 1.29-1.45 (m, 12H); 13C NMR
(75 MHz, CDCl3): δ 168.5, 139.2, 114.3, 71.4, 43.0, 34.8, 33.8,
29.4 (2C), 29.2, 29.1, 29.0, 25.0; MS (EI, 70 eV): m/z 167, 150,
135, 121, 109, 95, 81, 67. HRMS (FAB) m/z cacld for C13H22O2:
210.1620. Found: 210.1626.
(S)-4-(Ben zyloxylm eth yl)oxeta n -2-on e (2h ).2a The general
procedure was followed employing 250 mg of 4-(benzyloxylm-
ethyl)oxetan-2-one (1h ) and 113 mg of benzyl alcohol (72 h
reaction time). Column chromatography (60% pentane, 30%
ethyl ether, 10% toluene) of the crude reaction mixture afforded
110 mg of the title compound (44%). Separation of the enanti-
omers by chiral HPLC (Daicel Chiracel OD-H column, flow rate
1
(NaCl): 1826 cm-1; H NMR (300 MHz, CDCl3): δ 4.51 (ddt, J
) 7.4, 5.9, 4.4 Hz, 1H), 3.51 (dd, J ) 16.3, 5.8 Hz, 1H), 3.07 (dd,
J ) 16.3, 4.3 Hz, 1H), 1.86 (m, 1H), 1.78 (m, 1H), 1.39 (m, 4H),
0.93 (t, J ) 6.7, 3H); 13C NMR (75 MHz, CDCl3): δ 168.3, 71.0,
42.4, 34.0, 26.6, 21.9, 13.5; MS (CI, isobutane): m/z 129 [M +
H]+, 111.
i
0.9 mL/min, 15% PrOH, 85% hexane Tr 14.1(R) and 23.0 (S)
min) determined the enantiomer ratio to be 11.5:1 (84%ee). [R]D
+21.9° (c 5.3, CH2Cl2).
(R)-4-P r op yloxeta n -2-on e (2e).8a The general procedure was
followed employing 1.0 g of 4-isopropyloxetan-2-one (1e) and 759
mg of benzyl alcohol (72 h reaction time). Column chromatog-
raphy (90% hexane, 10% ethyl acetate) of the crude reaction
mixture afforded 261 mg of the title compound (26%). Separation
of the enantiomers by chiral GC (Chiraldex G-TA column, flow
rate 0.5 mL/min, method: 100 °C for 10.00 min, ramp @ 10.00
°C/min to 130 °C for 8.00 min, ramp @ 10.00 °C/min to 160 °C
for 5.00 min, Tr 10.5 (R) and 11.2 (S) min) determined the
enantiomeric excess to be 98%. [R]D +25.9° (c 3.2, CH2Cl2). IR
(R)-4-(Ben zyloxy)-3-h yd r oxybu ta n oic Acid , Ben zyl Es-
ter (3h ). From the resolution of 1h described above, column
chromatography (60% pentane, 30% ethyl ether, 10% toluene)
of the crude reaction mixture afforded 187 mg of the title
compound (48%). Separation of the enantiomers via chiral HPLC
(Daicel Chiracel OD-H column, flow rate 0.9 mL/min, 15%
iPrOH, 85% hexane Tr 12.8 (S) and 15.8 (R) min) determined
the enantiomer ratio to be 50:1 (96% ee). [R]D +6.8° (c 1.7, CH2-
1
Cl2); IR (NaCl) 1733 cm-1; H NMR (300 MHz, CDCl3) δ 7.38-
1
(NaCl): 1826 cm-1; H NMR (300 MHz, CDCl3): δ 4.53 (ddt, J
7.27 (m, 10H), 5.31 (s, 2H), 4.56 (s, 2H), 4.27 (m, 1H), 3.53 (dd,
J ) 9.6 and 4.5 Hz, 1H) 3.48 (dd, J ) 9.6 and 6.5 Hz, 1H) 2.90
(br s, 1H), 2.59 (dd, J ) 18.6 and 6.3 Hz, 2H); 13C (75 MHz,
CDCl3) δ 171.9, 137.8, 135.5, 128.6, 128.4, 128.3, 128.2, 127.8,
127.7, 73.4, 73.0, 67.2, 66.5, 38.2; TLC Rf 0.15 (30% diethyl ether,
60% pentane, 10% toluene); MS (EI, 70 eV): m/z 300 (M+).
HRMS (FAB) m/z cacld for C11H13O4 (M+ - C7H7): 209.0814.
Found: 209.0812.
) 7.4, 5.8, 4.4 Hz, 1H), 3.52 (dd, J ) 16.2, 5.7 Hz, 1H), 3.07 (dd,
J ) 16.2, 4.3 Hz, 1H), 1.86 (m, 1H), 1.72 (m, 1H), 1.46 (m, 2H),
0.99 (t, J ) 7.3 Hz); 13C NMR (75 MHz, CDCl3): δ 168.2, 70.8,
42.4, 36.2, 17.9, 13.2; MS (CI, isobutane): m/z 115 [M + H]+,
97, 73.
(R)-4-(2-Meth ylp r op yl)oxeta n -2-on e (2f). The general pro-
cedure was followed employing 500 mg of 4-(2-methylpropyl)-
oxetan-2-one (1f) and 338 mg of benzyl alcohol (72 h reaction
time). Column chromatography (90% hexane, 10% ethyl acetate)
of the crude reaction mixture afforded 200 mg of the title
compound (40%). Separation of the enantiomers by chiral GC
(Chiraldex G-TA column, flow rate 0.5 mL/min, method: 100
Assign m en t of Ster eoch em istr y. Stereochemical assign-
ment of the enantiomerically enriched â-lactones 2c and 2h was
made by their conversion to the corresponding 1,3-diol deriva-
tives and comparison of the specific rotations to literature values.
General procedure: Lithium aluminum hydride (2.0 equiv) was